Recall events
/
Event 83200
Event summary
Timeline bucket May 31, 2019
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Geritrex, LLC
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
8 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 8
Diphenhydramine Oral Liquid Alcohol Free, 12.5 mg/5 mL, 4 fl oz (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941, NDC 53807-204-04
D-1520-2019
Recall number D-1520-2019
Initiated May 31, 2019
Classification Class II
Status Terminated
Quantity 8645 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
Microbial contamination
reason.microbial_contamination · v1.0.0
microbial contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations: Products may have microbial contamination.
Code information Lot #: 70606, Exp 6/19
Distribution pattern U.S.A. Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11205]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 8
Ritussin DM Children & Adults, 4 Fl. Oz. (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941, NDC 53807-409-04
D-1521-2019
Recall number D-1521-2019
Initiated May 31, 2019
Classification Class II
Status Terminated
Quantity 5107 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
Microbial contamination
reason.microbial_contamination · v1.0.0
microbial contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations: Products may have microbial contamination.
Code information Lot #: 70602, Exp 6/19
Distribution pattern U.S.A. Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[10996]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 8
Gericare Diocto Liquid Docusate Sodium Stool Softener, 50 mg/5mL, 16 FL OZ (473 ml), Dist. BY: Gericare Pharmaceuticals corp. 1650 63rd Street Brooklyn, NY 11204, NDC 57896-403-16
D-1522-2019
Recall number D-1522-2019
Initiated May 31, 2019
Classification Class II
Status Terminated
Quantity 6165 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
Microbial contamination
reason.microbial_contamination · v1.0.0
microbial contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations: Products may have microbial contamination.
Code information Lot #: 70612, Exp 6/19
Distribution pattern U.S.A. Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11394]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 8
Gericare Iron Supplement Elixir Ferrous Sulfate, 220 mg, 16 fl oz. (473 mL), Distributed by: Geri-care Pharmaceuticals Corp. 1650 63rd Street Brooklyn, NY 11204, NDC 57896-709-16
D-1523-2019
Recall number D-1523-2019
Initiated May 31, 2019
Classification Class II
Status Terminated
Quantity 3789 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
Microbial contamination
reason.microbial_contamination · v1.0.0
microbial contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations: Products may have microbial contamination.
Code information Lot #: 70601, Exp 6/19
Distribution pattern U.S.A. Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11337]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 8
Preferred Plus Pharmacy Iron Elixir Ferrous Sulfate, 220 mg, 16 fl oz. (473 mL), Distributed by: Geri-care Pharmaceuticals Corp. 1650 63rd Street Brooklyn, NY 11204, NDC 52807-177-16
D-1524-2019
Recall number D-1524-2019
Initiated May 31, 2019
Classification Class II
Status Terminated
Quantity 3864 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
Microbial contamination
reason.microbial_contamination · v1.0.0
microbial contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations: Products may have microbial contamination.
Code information Lot #: 70601, Exp 6/19
Distribution pattern U.S.A. Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11499]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 8
Ritussin DM Double Strength, 4 FL. OZ. (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941
D-1525-2019
Recall number D-1525-2019
Initiated May 31, 2019
Classification Class II
Status Terminated
Quantity 7653 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
Microbial contamination
reason.microbial_contamination · v1.0.0
microbial contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations: Products may have microbial contamination.
Code information Lot #: 70611, Exp 6/19
Distribution pattern U.S.A. Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11563]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 8
Gericare Geri-Tussin DM, 16 FL OZ (473 mL), Geri-care Phamaceuticals Corp. 1650 63rd Street Brooklyn, NY, NDC 57896-660-16
D-1526-2019
Recall number D-1526-2019
Initiated May 31, 2019
Classification Class II
Status Terminated
Quantity 6213 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
Microbial contamination
reason.microbial_contamination · v1.0.0
microbial contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations: Products may have microbial contamination.
Code information Lot #: 70602, Exp 6/19
Distribution pattern U.S.A. Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[10964]
FDA event record
· Exact recall-number query on openFDA
drug · product 8 of 8
Preferred Plus Dioctyl Liquid Stool Softener (Docusate Sodium), 50mg/5mL, 16 FL. Oz. (1 PT.) 473 mL, Manufactured by RIJ Pharmaceutical Corp. 40 Commercial Avenue Middletown, NY 10941, Distributed by Kinray Inc. Whitestone, NY 11357, NDC 53807-216-16
D-1527-2019
Recall number D-1527-2019
Initiated May 31, 2019
Classification Class II
Status Terminated
Quantity 15435 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
Microbial contamination
reason.microbial_contamination · v1.0.0
microbial contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations: Products may have microbial contamination.
Code information Lot #: 70603, 70604, 70612, Exp 6/19
Distribution pattern U.S.A. Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11478]
FDA event record
· Exact recall-number query on openFDA
